Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Osaka Yuka Industry Ltd. (4124.T)
Hirakata, JP
Osaka Yuka Industry Ltd. specializes in delivering precision distillation services throughout Japan. Its project portfolio includes undertaking small-scale distillation for research purposes, executing precise distillation of diverse chemical compounds, and providing support for integrating compact distillation equipment and associated apparatuses into industrial facilities. The company, which has its headquarters in Hirakata, Japan, was established in 1948.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.04% | -5.36% | -2.61% | +8.52% | +4.62% | +8.39% | +9.42% | +76.36% | +44.75% | -30.29% | -30.29% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+19.3% ★ Q1'26: +77.5% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-51,710.7% Q1'26: +629.2% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%+20.6% Q1'26: +34.5% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+11.8% ★ Q1'26: +23.5% (vs Q1'25)
-
ROIC Chemicals: +3.4%+10.8% ★ Q1'26: +31.8% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+0.3% Q1'26: -18.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×0.00× ★ Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Sep 2017 actual |
Sep 2018 actual |
Sep 2019 actual |
Sep 2020 actual |
Sep 2021 actual |
Sep 2022 actual |
Sep 2023 actual |
|---|---|---|---|---|---|---|---|
| Revenue |
1.14B
est: 1.13B (+0.7%)
|
1.21B
est: 1.20B (+1.2%)
|
1.09B
est: 1.09B (-0.4%)
|
1.05B
est: 1.26B (-16.7%)
|
1.22B
est: 982.00M (+23.8%)
|
1.18B
est: 1.12B (+5.6%)
|
1.24B
est: 1.27B (-2.4%)
|
| EBITDA |
335.78M
est: 227.38M (+47.7%)
|
298.51M
est: 241.46M (+23.6%)
|
223.06M
est: 219.93M (+1.4%)
|
250.24M
est: 253.94M (-1.5%)
|
251.84M
est: 197.60M (+27.5%)
|
286.34M
est: 224.96M (+27.3%)
|
249.70M
est: 254.54M (-1.9%)
|
| EBIT |
220.31M
est: 98.93M (+122.7%)
|
201.84M
est: 105.06M (+92.1%)
|
107.69M
est: 95.69M (+12.5%)
|
111.84M
est: 110.49M (+1.2%)
|
117.85M
est: 85.98M (+37.1%)
|
137.47M
est: 97.88M (+40.4%)
|
115.37M
est: 110.75M (+4.2%)
|
| Net Income |
139.72M
est: 229.30M (-39.1%)
|
115.62M
est: 166.88M (-30.7%)
|
72.90M
est: 64.89M (+12.3%)
|
75.30M
est: 103.64M (-27.4%)
|
80.41M
est: 18.70M (+329.9%)
|
88.23M
est: 61.90M (+42.5%)
|
-8.67M
est: 113.05M (-107.7%)
|
| SGA |
242.20M
est: 378.47M (-36.0%)
|
306.16M
est: 401.91M (-23.8%)
|
305.87M
est: 366.07M (-16.4%)
|
296.27M
est: 422.68M (-29.9%)
|
386.02M
est: 328.90M (+17.4%)
|
383.06M
est: 374.45M (+2.3%)
|
417.47M
est: 423.68M (-1.5%)
|
| EPS |
148.77
est: 221.90 (-33.0%)
|
111.49
est: 161.50 (-31.0%)
|
68.37
est: 62.80 (+8.9%)
|
71.55
est: 100.30 (-28.7%)
|
76.25
est: 18.10 (+321.3%)
|
83.24
est: 59.90 (+39.0%)
|
-8.38
est: 109.40 (-107.7%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-14 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-13 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-12 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-11 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-08 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-07 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-01 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-30 | B | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Naoki Nomura | Senior MD, GM of Manufacturing Department & Factory Manager, COO and Director | — | male |
| Teppei Hotta | President, Chief Executive Officer & Chairman | — | male |
| Yoshihiro Tomura | GM of Technical Sales Department & Director | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4124.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
